Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

Clinical trial NCT04900454 · COMPLETED

Trial details

NCT number: NCT04900454
Sponsor: Coeptis Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2021-08-01
Primary completion: 2022-06-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.